391 related articles for article (PubMed ID: 22208450)
1. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
[TBL] [Abstract][Full Text] [Related]
2. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
Mendonça DA; Menezes K; Jog MS
Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
[TBL] [Abstract][Full Text] [Related]
5. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
[TBL] [Abstract][Full Text] [Related]
6. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
Nutt JG; Carter JH; Carlson NE
Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
8. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; El Osta B; Valero V; Driver LC; Pei BL; Shen L; Poulter VA; Palmer JL
J Clin Oncol; 2007 Aug; 25(23):3475-81. PubMed ID: 17687152
[TBL] [Abstract][Full Text] [Related]
9. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
[TBL] [Abstract][Full Text] [Related]
11. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
[TBL] [Abstract][Full Text] [Related]
12. Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients.
Centeno C; Sanz A; Cuervo MA; Ramos D; Hernansanz S; Gonzalez J; Almaraz MJ; Lama M; Vara F; Nabal M; Pascual A
BMJ Support Palliat Care; 2012 Dec; 2(4):328-33. PubMed ID: 24654216
[TBL] [Abstract][Full Text] [Related]
13. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
18. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.
Lower EE; Fleishman S; Cooper A; Zeldis J; Faleck H; Yu Z; Manning D
J Pain Symptom Manage; 2009 Nov; 38(5):650-62. PubMed ID: 19896571
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
